ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

CDMO for EMBED 3.0 Research Study

Cardiff University · Contract award notice on Find a Tender

Tender information last checkedLast checked 2 Oct 2026, 15:27.

Opportunity overview

Due to the highly specific technical requirements regarding product manufacture (microinjection-moulding (MIM) of formulations containing API) it rapidly became clear that we needed to separate the production from the clinical trial services and identify separate vendors for these services. At the current stage of the program, the identification and selection of a Contract Development and Manufacturing Organization (CDMO) was prioritized by the EMBED team and the funder.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

ProMed Pharma, LLC

No match
Published award value
US$325k
Awarded
26 Apr 2026
Award ID
1
Status
pending
Identifier
GB-PPON PRNX-3276-XWMG
Location
Minneapolis, US, MN 55311, United States

Classification

No classification was supplied.

Lots

  • Lot 1Value not stated

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-068b66
Status
complete
Procurement Method
direct
Procurement Method Details
Direct award

Legal basis

Id
2023/54
Scheme
UKPGA

Lots and requirements

Entry 1
Id
1
Status
complete

Buyer, suppliers and contacts

Organisation 1
Name
Cardiff University
Id
GB-PPON-PHVT-4343-HWYR

Identifier

Scheme
GB-PPON
Id
PHVT-4343-HWYR

Address

Street Address
Procurement Services
Locality
Cardiff
Postal Code
CF24 4HQ
Country
GB
Country Name
United Kingdom
Region
UKL22

Contact

Roles

buyer

Details

Classifications

Entry 1
Scheme
UK_CA_TYPE
Id
publicAuthoritySubCentralGovernment
Description
Public authority - sub-central government
Entry 2
Scheme
UK_CA_DEVOLVED_REGULATIONS
Id
GB-WLS
Description
Welsh devolved regulations apply
Organisation 2
Name
ProMed Pharma, LLC
Id
GB-PPON-PRNX-3276-XWMG

Identifier

Scheme
GB-PPON
Id
PRNX-3276-XWMG

Address

Street Address
6765 Wedgwood Road, Maple Grove
Locality
Minneapolis
Postal Code
MN 55311
Country
US
Country Name
United States
Region
US

Contact

Roles

supplier

Details

Scale
large
Vcse
No
Public Service Mission Organization
No
Sheltered Workshop
No

Award information

Award 1
Id
1
Title
EMBED 3.0 Contraceptive Microneedle Development
Status
pending
Date
27 Apr 2026, 00:00
Main Procurement Category
services
Above Threshold
Yes

Items

Item 1
Id
1
Related Lot
1

Additional Classifications

Entry 1
Scheme
CPV
Id
73100000
Description
Research and experimental development services

Delivery locations

Entry 1
Region
UKL22
Country
GB
Country Name
United Kingdom

Value

Including VAT
325,000
Amount
325,000
Currency
USD

Suppliers

Supplier 1
Id
GB-PPON-PRNX-3276-XWMG
Name
ProMed Pharma, LLC

Standstill Period

Ends
7 May 2026, 23:59

Contract period

Starts
11 May 2026, 00:00
Ends
31 Dec 2026, 23:59

Related lots

1

Documents

Entry 1
Id
038100-2026
Document Type
awardNotice
Notice Type
UK6
Description
Contract award notice on Find a Tender
Published
27 Apr 2026, 14:40
Format
text/html

Milestones

Entry 1
Id
1
Type
futureSignatureDate
Due
8 May 2026, 23:59
Status
scheduled

Recorded locations

  • Buyer location · Cardiff · UKL22 · CF24 4HQ · United Kingdom

Notice and amendment history

2 published notice versions reviewed by ProcuraAxis.

2 VERSIONS
  1. 037949-2026Transparency notice on Find a Tender ·
  2. 038100-2026Contract award notice on Find a Tender ·